BNO 5.26% 20.0¢ bionomics limited

And Oncology x2 sale by the end of this year and early next and...

  1. 14 Posts.
    lightbulb Created with Sketch. 1
    And Oncology x2 sale by the end of this year and early next and Merck milestone payment (potentially) early next year for BNC375 moving into Phase 2 trial. (another 20 to 30mil)
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.